Rate My Professor Morgayn Read

Read's research interests bridge cardiovascular pharmacology and neurological diseases. In cardiovascular physiology, her work addresses seizure-induced cardiomyopathy, bradycardia, cardiomyopathies, heart rate variability, electrocardiography, and echocardiography. Key outputs include the first-author publication 'Improved cardiac outcomes with combined atenolol and lacosamide treatment in a preclinical model of chronic epilepsy-associated cardiomyopathy' in Epilepsia (2018), and co-authorship on a 2020 patent 'Carbon monoxide releasing norbornenone compounds' for cardioprotective applications. Extending to neurology, she has published reviews on Alzheimer's disease, such as 'Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks' (2021), 'Trehalose against Alzheimer's Disease: Insights into a Potential Therapy' (2020), 'Curcumin: an inflammasome silencer' (2020), 'Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease' (2020), and 'Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases' (2021). Her publications have received over 900 citations. Read teaches courses including PHCY 340 Essentials of Drug Action and PHAL 211 Introduction to Pharmacology and Toxicology.